Home
Home

blisibimod

Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod

Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
Yahoo

Anthera Pharmaceuticals Trading Higher On Additional Data; Need For Capital Could Cap Upside

Anthera Pharmaceuticals Trading Higher On Additional Data; Need For Capital Could Cap Upside
Seeking Alpha

Anthera's Lupus Drug Gets Second Chance After Clinical Trial Disaster

Anthera's Lupus Drug Gets Second Chance After Clinical Trial Disaster
Seeking Alpha

Anthera announces advancement of blisibimod in Phase 3 development

Anthera announces advancement of blisibimod in Phase 3 development
The Fly on the Wall

Anthera plunges on drug study

Anthera plunges on drug study
Marketwatch

A Long Shot In The Lupus Market Gains Attention

A Long Shot In The Lupus Market Gains Attention
Seeking Alpha